First PI3K Inhibitor Approved for Metastatic, Advanced Breast Cancer

Piqray approved for HR-positive, HER2-negative, PIK3CA-mutated, metastatic or advanced breast cancer

from General Cancer News Articles Provided by Cancer Compass http://bit.ly/2JL0euq